Clinical trial
Observatory for Patients Treated for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia With Oncogenetic Features.
NCT05832125 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observatory for Patients Treated for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia With Oncogenetic Features.
- Lead sponsor
- Versailles Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 14, 2021
- Completion date
- March 31, 2024
- Enrollment
- 80 (estimated)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
relapsed/refractory acute lymphoblastic leukemia, t-cell acute lymphoblastic leukemia